BeStock  
Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3607BiotechnologyAI medical concept stocks
$7.46 −$0.74 (-9.02%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.55 +1.21%
Open$7.93
Prev close$8.20
Day range$7.38 – $8.29
Volume2.51M
Market cap$483.59M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

DNA at a glance

Shares of Ginkgo Bioworks are down 9.02% at $7.46. The company is worth $483.59M, number 3607 out of 3753 on our list.

Over the past 52 weeks it has traded between $5.37 and $18.22, so it sits 59.1% below the top of that range. Holders are behind 8.7% over twelve months, but up 10.0% across the last three months.

On the chart it has slipped under both the 50-day ($10.42) and 200-day ($8.63) moving averages; RSI is 37, and the last 30 sessions moved at roughly 137% annualized volatility.

In the quarter ended Sep 2026 the company brought in $27.71M of revenue, down 5.7% from a year earlier, and a net loss of $40.98M.

1 analysts follow the stock and the average call is "sell". The mean target, $5.00, sits 33.0% under where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$7.44 / $7.70
Average price today$7.67
Volume2.51MAvg (90d) 2.12M
Turnover$19.26M
Turnover rate4.81%of shares outstanding
Volume ratio0.96vs. recent average pace
Day amplitude11.10%
Market cap$483.59M
Float market cap$389.24M
Shares outstanding52.18M
EPS (TTM)-$5.64
P/B1.23
Book value / share$6.06
Net profit (TTM)-$365.61M
Net assets$392.65M
30-day volatility137.1%annualized
Avg daily range (ATR)16.93%of price, 14 days
Max drawdown (1y)-50.2%-50.2% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

F
Wall Street

1 analysts, consensus Sell.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 4.6 · 2026-11-14 20:27 UTC. Higher values indicate a stronger relative ranking. Snapshot refresh is overdue.

FactorPercentile
Valuation—
Growth—
Profitability15.0
Momentum75.2
Financial health24.3
Analyst view0.3

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$5.00-33.0% vs. current price
Consensus ratingSell1 analysts covering
Morningstar fair value$18.65Price is below fair value

Wall Street’s average 12-month target is $5.00, 33.0% below today’s price, with a consensus rating of Sell. Morningstar’s fair value model puts the stock at $18.65, so shares trade 60.0% below that estimate. On earnings multiple, it sits in the 30th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-9.0%
1 week
-22.4%
1 month
-23.2%
3 months
+10.0%
6 months
-11.3%
Year to date
-10.2%
1 year
-8.7%
Day range
$7.38$8.29
52-week range
$5.37$18.22

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-28.1%Bearish
Price vs 50-day average-28.4%Bearish
Price vs 200-day average-13.5%Bearish
50-day vs 200-day50d above 200dBullish
RSI (14)36.9Bearish
MACD (12,26,9)-0.68Bearish
Bollinger band position6%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How DNA ranks on BeStock

Market value#3589 of 3734
Closeness to 52-week high#3304 of 3724
Dollar volume today#2032 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

DNA is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on DNA.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on DNA

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

DNA stock: common questions

Where is DNA trading right now?

$7.46 is the latest print for DNA, a move of -9.02% against yesterday's close of $8.20. Today's low and high so far: $7.38 and $8.29.

How big is Ginkgo Bioworks?

Equity value comes to $483.59M at the current price. By that measure it is number 3607 of the 3753 names in our coverage.

Where does DNA sit in its 52-week range?

The year's floor is $5.37 and the ceiling $18.22. Shares are 59.1% away from that ceiling.

Does DNA send cash back through a dividend?

Our data shows no dividend paid by Ginkgo Bioworks over the trailing twelve months.

Do Wall Street analysts like DNA?

Of 1 analysts, 0% say buy, 0% hold and 100% sell. Price targets average $5.00, with the most cautious at $5.00 and the most optimistic at $5.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on DNA.

Sign in to join the discussion.

Scroll to Top